CMR FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schroeder, G. N.
Right arrow Articles by Hilbi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schroeder, G. N.
Right arrow Articles by Hilbi, H.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2008, p. 134-156, Vol. 21, No. 1
0893-8512/08/$08.00+0     doi:10.1128/CMR.00032-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Molecular Pathogenesis of Shigella spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion

Gunnar N. Schroeder and Hubert Hilbi*

Institute of Microbiology, ETH Zürich, Wolfgang Pauli Strasse 10, 8093 Zürich, Switzerland

Shigella spp. are gram-negative pathogenic bacteria that evolved from harmless enterobacterial relatives and may cause devastating diarrhea upon ingestion. Research performed over the last 25 years revealed that a type III secretion system (T3SS) encoded on a large plasmid is a key virulence factor of Shigella flexneri. The T3SS determines the interactions of S. flexneri with intestinal cells by consecutively translocating two sets of effector proteins into the target cells. Thus, S. flexneri controls invasion into EC, intra- and intercellular spread, macrophage cell death, as well as host inflammatory responses. Some of the translocated effector proteins show novel biochemical activities by which they intercept host cell signal transduction pathways. An understanding of the molecular mechanisms underlying Shigella pathogenesis will foster the development of a safe and efficient vaccine, which, in parallel with improved hygiene, should curb infections by this widespread pathogen.


* Corresponding author. Mailing address: ETH Zürich, Institute of Microbiology, Wolfgang Pauli Strasse 10, HCI G405, 8093 Zürich, Switzerland. Phone: (41) 44 632 4782. Fax: (41) 44 632 1137. E-mail: hilbi{at}micro.biol.ethz.ch


Clinical Microbiology Reviews, January 2008, p. 134-156, Vol. 21, No. 1
0893-8512/08/$08.00+0     doi:10.1128/CMR.00032-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Vaccine Immunol.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.